Join us as we dive into a conversation about the benefits of NAD, the importance of clean living, and the emerging role of psychedelics in therapy. Our host shares his personal journey of going 60 days clean and the transformative effects of NAD on his physical performance. We also explore the latest news on MDMA-assisted therapy for PTSD, including congressional support and the need for proper training and planning. From the potential of psychedelic retreats to the importance of therapist-patient relationships in psychedelic therapy, this episode covers a range of topics at the intersection of wellness, mental health, and innovative treatments. Tune in to learn about the latest advancements and hear firsthand experiences that could shape the future of health and wellness.

Join Daniel and Cody as they dive into the shocking news from the FDA's advisory committee review. We'll set the stage with an in-depth look at the independent panels of researchers, insurance executives, and doctors who play a crucial role in drug approval. Discover why the MAPS program, integrating psychotherapy with new drug trials, has turned the review process upside down. They'll discuss the controversies, including trial design issues, racial disparities among participants, and the surprising rejection of a breakthrough PTSD treatment. Is there a deeper bias within the FDA, or is it a matter of incompetence from the drug development team at Lycos Therapeutics?  Explore the impact on veterans and PTSD survivors, the future of therapies like MDMA and ketamine, and how companies like Healing Realty Trust are navigating these turbulent waters. Tune in for a critical analysis and personal opinions on the FDA's decision, its implications for mental health treatment, and what it means for the future of drug development and approval.

In this episode, our host shares a transformative experience with psilocybin mushrooms in Oregon. Discover how this high-dose ceremony brought clarity, confidence, and positive life changes. Learn about Measure 109, which allows legal access to psilocybin therapy in Oregon, and its potential for personal healing. Whether you're curious about psychedelics or seeking inspiration, this episode offers simple insights into the power of psilocybin for mental and spiritual growth.

In this episode we delve into the complex landscape of marijuana legislation in Florida with renowned marijuana attorney, Peyton. As the state grapples with evolving regulations and attitudes toward cannabis, we uncover the latest developments and key insights that affect consumers, businesses, and the legal community alike. Join us as we explore the intricacies of Florida's cannabis laws, from medical marijuana regulations to recent legislative changes. Peyton provides expert analysis and valuable perspectives on the challenges and opportunities facing individuals and businesses involved in the marijuana industry.

Journey into the world of psychedelic therapy, where ancient wisdom meets modern science, and healing knows no bounds. This is 'Bring it on Home,' where we open the doors to a new era of healing and transformation. Onward!

In this episode of "Bring it on Home," we delve into the fascinating realm of psychedelic therapy for neurological damage. Join us as we uncover the groundbreaking research surrounding psilocybin and other psychedelics, and their potential to heal and regenerate the brain. From traumatic brain injuries to neurodegenerative diseases like Parkinson's and Alzheimer's, we explore the promising results emerging from clinical trials and personal anecdotes. Listen in as we navigate the science, the stories, and the profound implications of using these mind-altering substances as tools for neurological recovery. Strap in for a journey into the unknown as we discuss how these ancient compounds are bringing hope and healing to the forefront of modern medicine.

Daniel speaks to his recovery journey from 7 diagnosed concussions using mushroom therapy, questions why the NHL continues to deny a link between repetitive head trauma and neurodegenerative disease after Chris Simon’s public struggles with CTE before his recent death, and details the companies who are developing emerging & psychedelic molecules through the FDA.

Daniel and Cody dive into the emerging science and data coming out of institutions like Johns Hopkins and from the FDA clinical trials, explain how these substances can and will impact the healthcare landscape and improve the mental health of countless individuals in the future.

In our latest episode of the Bring It On Home podcast, Cody and Daniel give a weekly update on the psychedelic industry and how quickly it is evolving with 5 companies now holding FDA BREAKTHROUGH THERAPY DESIGNATIONS for 5 different compounds.   Compass Pathways with synthetic psilocybin to treat treatment resistant depression, Usona with synthetic psilocybin to treat major depressive disorder, Cybin with synthetic psilocybin to major depressive disorder, Mindmed with LSD to treat anxiety disorders, and Lykos Therapeutics with MDMA to treat PTSD.   These emerging medicines get to the root cause of someone's issues and allow them to move past their trauma so it does not govern the rest of their life.

Daniel and Cody talk about the recent events held by Healing Realty Trust and the momentum it’s created. They also cover the relaunch of Dan’s website DanielCarcillo.com and what he hopes to accomplish with his platform.